loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of Health Canada Patents covering Exenatide.

    Client Email Product
    Menu

    Exenatide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    CLINICAL TRIALS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AstraZeneca Canada Inc. (11)

    filter

    01 2262647 (3)

    02 2277112 (3)

    03 2356706 (2)

    04 2560874 (1)

    05 2560981 (1)

    06 2619426 (1)

    filter

    01 EXENATIDE (5)

    02 Exenatide (6)

    filter

    01 POWDER FOR SUSPENSION, SUSTAINED-RELEASE (5)

    02 Solution for injection in 1.2 mL pre-filled pens (3)

    03 Solution for injection in 2.4 mL pre-filled pens (3)

    filter

    01 2017-08-08 (3)

    02 2018-07-01 (3)

    03 2020-01-14 (2)

    04 2024-04-15 (1)

    05 2025-04-15 (1)

    06 2026-08-18 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2277112
    250 ┬╡g / mL
    Solution for injection in 1.2 mL pre-filled pens
    Human
    2018-07-01
    2008-08-26
    1998-07-01
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2277112
    250 ┬╡g / mL
    Solution for injection in 2.4 mL pre-filled pens
    Human
    2018-07-01
    2008-08-26
    1998-07-01
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2262647
    250 ┬╡g / mL
    Solution for injection in 2.4 mL pre-filled pens
    Human
    2017-08-08
    2007-04-12
    1997-08-08
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2262647
    250 ┬╡g / mL
    Solution for injection in 1.2 mL pre-filled pens
    Human
    2017-08-08
    2007-04-12
    1997-08-08
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2356706
    250 ┬╡g / mL
    Solution for injection in 2.4 mL pre-filled pens
    Human
    2020-01-14
    2014-09-30
    2000-01-14
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2356706
    250 ┬╡g / mL
    Solution for injection in 1.2 mL pre-filled pens
    Human
    2020-01-14
    2014-09-30
    2000-01-14
    BYETTA
    Subcutaneous Injection
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2619426
    2 mg / dose
    POWDER FOR SUSPENSION, SUSTAINED-RELEASE
    Human
    2026-08-18
    2016-06-21
    2006-08-18
    BYDUREON
    SUBCUTANEOUS
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2560874
    2 mg / dose
    POWDER FOR SUSPENSION, SUSTAINED-RELEASE
    Human
    2025-04-15
    2013-02-19
    2005-04-15
    BYDUREON
    SUBCUTANEOUS
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2560981
    2 mg / dose
    POWDER FOR SUSPENSION, SUSTAINED-RELEASE
    Human
    2024-04-15
    2013-02-19
    2004-04-15
    BYDUREON
    SUBCUTANEOUS
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    AstraZeneca Canada Inc.

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Exenatide

    PDF Supplier PDF
    URL Supplier Web Content
    2262647
    2 mg / dose
    POWDER FOR SUSPENSION, SUSTAINED-RELEASE
    Human
    2017-08-08
    2007-04-12
    1997-08-08
    BYDUREON
    SUBCUTANEOUS
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY